Disclaimer:

Disclaimer: The blog posts and comments on this blog and posts on social networks are not investment recommendation, are provided solely for informational purposes, and do not constitute an offer or solicitation to buy or sell any securities. The opinions expressed on the blog are Petar Posledovich's. Petar Posledovich does not guarantee the accuracy of the information presented on this blog and social networks. The information presented is "as is". The blog is stocks analysis and valuation, Bitcoin, Cryptocurrencies, Artificial Intelligence, AI, deep-learning focused. Independent, unbiased AI insights. Petar Vladimirov Posledovich is not liable for any investment losses incurred by reading and interpreting blog posts on this blog and posts on social networks. Conflicts of interest: I may possess some of the securities, currencies or their derivatives mentioned in the blog post and posts on social networks! The blog is property of Wolfteam Ltd. www.wolfteamedge.com Respectfully yours, Petar Posledovich

Monday, September 12, 2022

Bavarian Nordic Prospects


Bavarian Nordic, the only firm to have an approved monkeypox vaccine and that is used currently can increase its market capitalisation from the current circa 3 billion USD to 70 billion USD, I think.

Monkeypox is spreading fast and if contracted it can have a devastating effect on the organism of human beings.

Countries the world over are too slow to respond to the monkeypox threat, which increases the fear factor and raises the probability of a global, deadly monkeypox virus pandemic.

No comments: